DANAHER CORP /DE/

Danaher is a science and technology innovator that develops products and services to advance human health. The company operates through more than fifteen operating companies divided into three primary segments: Biotechnology, Life Sciences, and Diagnostics. Biotechnology provides bioprocessing equipment, consumables, filtration technologies, and analytical tools used to research and manufacture biotherapeutics such as vaccines and gene therapies. Life Sciences supplies instruments, consumables, software, and filtration solutions, including mass spectrometers, microscopes, and custom nucleic acids, for genomic and cellular research. Diagnostics offers biomedical testing instruments, clinical lab systems, and diagnostic consumables to analyze bodily fluids, detect infections, and support medical treatment decisions. Its customers include biopharmaceutical companies, research institutions, clinical laboratories, hospitals, and physician practices.

The company maintains research, manufacturing, sales, distribution, service, and administrative facilities across approximately 50 countries, with primary manufacturing operations located in North America, Europe, Asia, and Australia. Danaher employs approximately 60,000 associates globally, with its workforce distributed across North America, Western Europe, and high-growth markets. The provided text does not state the location of the company's headquarters.

Summary of the business section of Danaher's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, the Company had approximately 60,000 employees (whom we refer to as “associates”), of whom approximately 22,000 were employed in North America, 20,000 in Western Europe, 3,000 in other developed markets and 15,000 in high-growth markets.”